KFDA Establishes Guidance for Combination Products

Published: 2005-02-17 06:58:00

Updated: 2005-02-17 06:58:00

Reflective of ongoing technological and scientific advances that merge various therapeutic agents into multi-purpose combination products, the Korea Food and Drug Administration (KFDA) announced on February 15th that it has established guidance and regulations on the timely and effective manageme...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK